These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26203600)
1. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets. Keskin M; Savaş-Erdeve Ş; Sağsak E; Çetinkaya S; Aycan Z J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1333-7. PubMed ID: 26203600 [TBL] [Abstract][Full Text] [Related]
2. Effects of therapy in X-linked hypophosphatemic rickets. Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098 [TBL] [Abstract][Full Text] [Related]
3. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse. Alon U; Donaldson DL; Hellerstein S; Warady BA; Harris DJ J Pediatr; 1992 Jun; 120(6):899-905. PubMed ID: 1317418 [TBL] [Abstract][Full Text] [Related]
4. Nephrocalcinosis and its relationship to treatment of hereditary rickets. Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887 [TBL] [Abstract][Full Text] [Related]
5. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth. Kooh SW; Binet A; Daneman A Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848 [TBL] [Abstract][Full Text] [Related]
6. Hereditary hypophosphatemic rickets with hypercalciuria: case report. Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288 [TBL] [Abstract][Full Text] [Related]
7. Nationwide Turkish Cohort Study of Hypophosphatemic Rickets. Şıklar Z; Turan S; Bereket A; Baş F; Güran T; Akberzade A; Abacı A; Demir K; Böber E; Özbek MN; Kara C; Poyrazoğlu Ş; Aydın M; Kardelen A; Tarım Ö; Eren E; Hatipoğlu N; Büyükinan M; Akyürek N; Çetinkaya S; Bayramoğlu E; Selver Eklioğlu B; Uçaktürk A; Abalı S; Gökşen D; Kor Y; Ünal E; Esen İ; Yıldırım R; Akın O; Çayır A; Dilek E; Kırel B; Anık A; Çatlı G; Berberoğlu M J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):150-159. PubMed ID: 31514490 [TBL] [Abstract][Full Text] [Related]
8. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets. Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA Nephron; 1993; 64(4):526-31. PubMed ID: 8396209 [TBL] [Abstract][Full Text] [Related]
9. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets. Reusz GS Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931 [TBL] [Abstract][Full Text] [Related]
10. Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy. Sun GE; Suer O; Carpenter TO; Tan CD; Li-Ng M Endocr Pract; 2013; 19(1):e8-e11. PubMed ID: 23186962 [TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of children with hypophosphataemic rickets]. Rahbek ET; Nielsen LH; Beck-Nielsen SS; Christesen HT Ugeskr Laeger; 2014 Feb; 176(9A):V10130629. PubMed ID: 25350412 [TBL] [Abstract][Full Text] [Related]
17. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745 [TBL] [Abstract][Full Text] [Related]
18. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503 [TBL] [Abstract][Full Text] [Related]
19. Medical management and complications of X-linked hypophosphatemic vitamin D resistant rickets. Ono T; Seino Y Acta Paediatr Jpn; 1997 Aug; 39(4):503-7. PubMed ID: 9316301 [TBL] [Abstract][Full Text] [Related]